0
Skip to Content
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Support Us
  • Participation,
• 15/12/2023

Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023

Previous

Testimonial of Lauren Macdonald, cancer patient, delivered at the PsyPal launch event

Next

Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression

You Might Also Like

Related Embedded Video Item Thumbnail Presentation of the results of ketamine-assisted therapy program for treatment resistant depression
Related Embedded Video Item Thumbnail The promise of psychedelic-assisted therapies
Related Embedded Video Item Thumbnail PSYCH Symposium: The Future of Psychedelic Medicine in the EU
Related Embedded Video Item Thumbnail Ongoing trials investigating psychedelic-assisted therapies
Related Embedded Video Item Thumbnail Launch of the PsychedeliCare and MEP Action Group on Psychedelics in Healthcare at the European Parliament 06.02.2025

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy